scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1010068998 |
P356 | DOI | 10.1186/S12879-016-1683-Z |
P932 | PMC publication ID | 4952323 |
P698 | PubMed publication ID | 27436414 |
P50 | author | Margot Kuo | Q125344613 |
Mel Krajden | Q6810759 | ||
Naveed Zafar Janjua | Q39716263 | ||
Mark W. Tyndall | Q51002222 | ||
P2093 | author name string | Maria Alvarez | |
Amanda Yu | |||
Jason Wong | |||
Darrel Cook | |||
P2860 | cites work | Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population. | Q51862034 |
Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. | Q55270239 | ||
Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011 | Q57696129 | ||
Guidelines and recommendations on the prevention and control of hepatitis C. Laboratory Centre for Disease Control | Q71010861 | ||
The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting | Q21559628 | ||
Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants | Q28550601 | ||
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Historical trends and projected hospital admissions for chronic hepatitis C infection in Canada: a birth cohort analysis | Q34280145 | ||
Mortality among British Columbians testing for hepatitis C antibody | Q34645221 | ||
Treatment of hepatitis C: a systematic review | Q35223637 | ||
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response | Q35933802 | ||
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 | Q36035889 | ||
An area-based material and social deprivation index for public health in Québec and Canada. | Q38101693 | ||
Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. | Q40219302 | ||
A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events | Q41281705 | ||
Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study | Q41572035 | ||
Seroprevalence of hepatitis B and C virus infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey | Q42254162 | ||
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality | Q43766203 | ||
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention | Q45355364 | ||
P921 | main subject | Canada | Q16 |
hepatitis C | Q154869 | ||
P304 | page(s) | 334 | |
P577 | publication date | 2016-07-19 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort | |
P478 | volume | 16 |
Q36279118 | A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada |
Q40075326 | A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia |
Q50170882 | Cigarette Smoking in Persons Living with Hepatitis C: the National Health and Nutrition Examination Survey (NHANES), 1999-2014. |
Q54250496 | Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. |
Q58781532 | Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals |
Q63915920 | Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy |
Q42364607 | Hepatitis C cross-genotype immunity and implications for vaccine development |
Q38839753 | Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study |
Q39154932 | Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort. |
Q37363491 | The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC) |
Search more.